Meng and his colleagues demonstrated that knockdown of PKM2 expression using pshRNA-PKM2 effectively enhanced the radiosensitivity of NSCLC cell lines and xenografts [15]. This evidence concerns the gene PKM and non-small cell lung carcinoma.